About one in ten patients with chronic plaque psoriasis can expect to have sustained long term disease control with biologic drugs, experience from a UK dermatology centre suggests. After eight years of follow up, 12% (68) of 560 patients treated with biologics (17 infliximab, 38 etanercept, 239 adalimumab, 266 ustekinumab) showed enduring improvements in PASI ...
Real-world data shows long term efficacy of biologics in psoriasis
By Michael Woodhead
21 Jun 2019